The Unequal Toll of COVID-19 Deaths in Prisons
The Unequal Toll of COVID-19 Deaths in Prisons
批准号:
2241846
负责人:
Kristin Turney
金额:
$51.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2025-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project takes an in-depth look at mortality in U.S. prisons during the COVID-19 pandemic. COVID-19 has taken a devastating toll on prison populations across the United States. Incarcerated people have experienced a risk of infection five times higher and risk of death three times higher than people in the general population. Recent national data collection projects lack both demographic information on deaths and facility-level details about the characteristics of places where deaths have been concentrated. Such data collection gaps around prisons leave open questions about both the unequal repercussions of COVID-19 and the mechanisms by which people in some institutions fared better than others. Findings from this project provide the first systematic accounting of the total mortality toll in prisons across the United States—a necessary foundation for future planning for resiliency efforts.Three research questions are investigated. First, did the risk of facility-level death in prison—from COVID-19, other natural causes, and unnatural causes—during the pandemic (2020-2022) differ significantly from the facility-level risk of death in prisons in prior years (2013-2019)? Second, how are demographic characteristics associated with deaths in prisons, and did these associations differ during the pandemic from prior years? Third, how are state- and facility-level characteristics (including COVID-19 mitigation responses and carceral deprivation) associated with deaths during the pandemic? These questions are addressed by collecting (via state-by-state public records requests) and analyzing monthly facility-level data on all deaths among people in custody of each state Department of Corrections and the Federal Bureau of Prisons between 2013 and 2022. These data are supplemented and verified with 2013 data available through ICPSR, 2014-2019 count data available through the Bureau of Justice Statistics, and 2020-2022 data available through the National Death Index (NDI), vital statistics, and medical examiners’ offices.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Intergenerational Consequences of Incarceration
-
批准号:1542474
-
项目类别:Standard Grant
-
资助金额:$33.42万
-
财政年份:2015
-
负责人:Kristin Turney
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Toll 样受体(TLR)基因多态性与新生儿细菌性脑膜炎的相关性及机器学习风险预测模型的构建研究
-
批准号:2026JJ82247
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖镇宇
-
依托单位:
基于细胞衰老机制探讨Toll样受体在儿童脓毒性ARDS中的作用研究
-
批准号:JCZRLH202601308
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Toll-9-Spätzle信号通路调节昆虫精子
个体化的功能及机制解析
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:胡启豪
-
依托单位:
Toll样受体-4调节线粒体-内质网偶联和线粒体功能对绝经后骨质疏松症病程进展的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈奇
-
依托单位:
丝胶蛋白Ser-1来源活性肽靶向Toll9参与家蚕免疫防御的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙悦婷
-
依托单位:
BTK抑制剂选择性调控Toll样受体(TLRs)
治疗NK/T淋巴瘤 “ 高细胞因子血症 ”的
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:马华娟
-
依托单位:
地西他滨通过SAGE1基因调控Toll样受体信号通路降低DNMT3A-R882H突变AML柔红霉素耐药性的机制研究
-
批准号:2025JJ81126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:朱凯波
-
依托单位:
Toll信号通路调控埃及伊蚊ISCs抑制
DENV在中肠有效感染的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:张若男
-
依托单位:
Toll/TLR 介导的稻纵卷叶螟对苏云金芽孢杆
菌的免疫响应机制
-
批准号:Z24C140020
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨亚军
-
依托单位:
包裹Toll样受体7/8激动剂R848的CART纳米囊泡治疗复发/难治大B细胞淋巴瘤的疗效及机制研究
-
批准号:82300257
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:王扬
-
依托单位: